Lanean...
The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Ameet Sarpatwari and Aaron Kesselheim explore whether stripping branded drugs of trademark protection would improve the efficiency and fairness of health care.
Gorde:
| Argitaratua izan da: | PLoS Med |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Public Library of Science
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4747525/ https://ncbi.nlm.nih.gov/pubmed/26859662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1001955 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|